1. Home
  2. DBVT vs CPAC Comparison

DBVT vs CPAC Comparison

Compare DBVT & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DBVT

DBV Technologies S.A.

HOLD

Current Price

$17.61

Market Cap

769.4M

Sector

Health Care

ML Signal

HOLD

Logo Cementos Pacasmayo S.A.A. (Each representing five)

CPAC

Cementos Pacasmayo S.A.A. (Each representing five)

HOLD

Current Price

$10.26

Market Cap

905.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DBVT
CPAC
Founded
2002
1949
Country
France
Peru
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
769.4M
905.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
DBVT
CPAC
Price
$17.61
$10.26
Analyst Decision
Buy
Sell
Analyst Count
7
2
Target Price
$31.75
$10.15
AVG Volume (30 Days)
611.1K
204.0K
Earning Date
10-28-2025
02-13-2026
Dividend Yield
N/A
5.38%
EPS Growth
N/A
20.27
EPS
N/A
0.15
Revenue
$5,502,000.00
$601,081,883.00
Revenue This Year
$1,768.71
$9.96
Revenue Next Year
$1,028.88
$1.70
P/E Ratio
N/A
$13.84
Revenue Growth
N/A
6.18
52 Week Low
$3.30
$5.10
52 Week High
$26.19
$11.30

Technical Indicators

Market Signals
Indicator
DBVT
CPAC
Relative Strength Index (RSI) 49.42 66.28
Support Level $16.49 $10.04
Resistance Level $19.62 $10.39
Average True Range (ATR) 1.49 0.34
MACD -0.50 -0.04
Stochastic Oscillator 11.76 25.00

Price Performance

Historical Comparison
DBVT
CPAC

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: